Squarepoint Ops LLC Novo Nordisk A S Transaction History

Squarepoint Ops LLC

$62.8 Billion
Q3 2024

A detailed history of Squarepoint Ops LLC transactions in Novo Nordisk A S stock. As of the latest transaction made, Squarepoint Ops LLC holds 20,549 shares of NVO stock, worth $2.09 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

20,549

Previous 17,300 18.78%

Holding current value

$2.09 Million

Previous $2.47 Million 0.93%

% of portfolio

0.0%

Previous 0.0%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$119.07 - $145.42 $8.06 Million - $9.84 Million	-67,676 Reduced 76.71%	20,549 $2.45 Million
Q2 2024 Aug 14, 2024	BUY	$122.71 - $146.91 $7.02 Million - $8.41 Million	57,248 Added 184.81%	88,225 $12.6 Million
Q1 2024 May 15, 2024	BUY	$102.11 - $135.92 $3.16 Million - $4.21 Million	30,977 New	30,977 $3.98 Million
Q2 2023 Aug 14, 2023	BUY	$155.98 - $172.65 $7.45 Million - $8.25 Million	47,771 Added 462.72%	58,095 $9.4 Million
Q1 2023 May 15, 2023	SELL	$132.34 - $159.14 $519,831 - $625,101	-3,928 Reduced 27.56%	10,324 $1.64 Million
Q4 2022 Feb 14, 2023	BUY	$102.55 - $135.33 $577,766 - $762,449	5,634 Added 65.37%	14,252 $1.93 Million
Q3 2022 Nov 14, 2022	SELL	$95.28 - $116.93 $1.38 Million - $1.69 Million	-14,463 Reduced 62.66%	8,618 $859,000
Q2 2022 Aug 15, 2022	SELL	$103.24 - $121.81 $2.03 Million - $2.4 Million	-19,690 Reduced 46.04%	23,081 $2.57 Million
Q1 2022 May 16, 2022	BUY	$93.1 - $112.54 $2.17 Million - $2.63 Million	23,349 Added 120.22%	42,771 $4.75 Million
Q4 2021 Feb 14, 2022	BUY	$95.88 - $117.08 $1.41 Million - $1.72 Million	14,707 Added 311.92%	19,422 $2.18 Million
Q3 2021 Nov 15, 2021	SELL	$84.42 - $106.62 $140,896 - $177,948	-1,669 Reduced 26.14%	4,715 $453,000
Q2 2021 Aug 16, 2021	SELL	$67.66 - $84.76 $3.87 Million - $4.85 Million	-57,194 Reduced 89.96%	6,384 $535,000
Q1 2021 May 17, 2021	BUY	$67.06 - $75.82 $2.17 Million - $2.45 Million	32,297 Added 103.25%	63,578 $4.29 Million
Q4 2020 Feb 16, 2021	BUY	$63.89 - $73.8 $896,632 - $1.04 Million	14,034 Added 81.37%	31,281 $2.19 Million
Q3 2020 Nov 16, 2020	SELL	$63.69 - $70.22 $2.37 Million - $2.61 Million	-37,169 Reduced 68.31%	17,247 $1.2 Million
Q2 2020 Aug 14, 2020	SELL	$58.54 - $67.94 $1.43 Million - $1.66 Million	-24,478 Reduced 31.03%	54,416 $3.56 Million
Q1 2020 May 15, 2020	SELL	$49.46 - $64.78 $3.77 Million - $4.93 Million	-76,133 Reduced 49.11%	78,894 $4.75 Million
Q4 2019 Feb 14, 2020	BUY	$49.86 - $58.26 $1.55 Million - $1.81 Million	31,100 Added 25.1%	155,027 $8.97 Million
Q3 2019 Nov 14, 2019	BUY	$47.54 - $53.43 $1.01 Million - $1.14 Million	21,327 Added 20.79%	123,927 $6.41 Million
Q2 2019 Aug 14, 2019	BUY	$46.79 - $52.47 $4.8 Million - $5.38 Million	102,600 New	102,600 $5.24 Million

Others Institutions Holding NVO

# of Institutions

1,953

Shares Held

320M

Call Options Held

5.49M

Put Options Held

7.78M

View Full List

About NOVO NORDISK A S

Ticker NVO
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 2,257,289,984
Market Cap $230B
Description
Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...

More about NVO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Squarepoint Ops LLC, based on Form 13F filings with the SEC.

News

Stay updated on Squarepoint Ops LLC with notifications on news.

Account

Squarepoint Ops LLC Novo Nordisk A S Transaction History